Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Marker Therapeutics (MRKR) Shares Outstanding (2016 - 2025)

Marker Therapeutics (MRKR) has disclosed Shares Outstanding for 11 consecutive years, with $16.7 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding rose 55.94% to $16.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $16.7 million through Dec 2025, up 55.94% year-over-year, with the annual reading at $16.7 million for FY2025, 55.94% up from the prior year.
  • Shares Outstanding for Q4 2025 was $16.7 million at Marker Therapeutics, roughly flat from $16.7 million in the prior quarter.
  • The five-year high for Shares Outstanding was $83.1 million in Q2 2021, with the low at $8.3 million in Q4 2021.
  • Average Shares Outstanding over 5 years is $21.0 million, with a median of $8.9 million recorded in 2024.
  • The sharpest move saw Shares Outstanding plummeted 89.95% in 2022, then soared 87.15% in 2025.
  • Over 5 years, Shares Outstanding stood at $8.3 million in 2021, then grew by 1.18% to $8.4 million in 2022, then grew by 5.78% to $8.9 million in 2023, then rose by 20.44% to $10.7 million in 2024, then skyrocketed by 55.94% to $16.7 million in 2025.
  • According to Business Quant data, Shares Outstanding over the past three periods came in at $16.7 million, $16.7 million, and $11.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.